Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01630343
Other study ID # QEHHIPPAIN
Secondary ID
Status Completed
Phase Phase 2
First received June 20, 2012
Last updated June 29, 2012
Start date January 2010
Est. completion date April 2012

Study information

Verified date June 2012
Source Queen Elizabeth Hospital, Hong Kong
Contact n/a
Is FDA regulated No
Health authority Hong Kong: Ethics Committee
Study type Interventional

Clinical Trial Summary

The Null Hypothesis is that there is no association between Pain regime and the functional performance among geriatric patients having traumatic hip fracture. Two limbs are being assessed:1. Three weeks of regular oral Panadol and Tramadol after hip fracture 2. Oral Panadol and tramadol taking in p.r.n. basis. Functional outcome including Numerical Rate Scale for pain assessment, Functional Independency Measure and Elderly Mobility Score are chosen.


Description:

200X2 patients are recruited during two periods within the study period where regular oral analgesics is given for the first 200 patients while the rest of patient will receive oral analgesics upon demand


Recruitment information / eligibility

Status Completed
Enrollment 400
Est. completion date April 2012
Est. primary completion date April 2012
Accepts healthy volunteers No
Gender Both
Age group 65 Years and older
Eligibility Inclusion Criteria:

- Both sex of Age > 65

- Traumatic non-pathological fracture neck of femur or trochanteric or subtrochanteric fracture having operative intervention

Exclusion Criteria:

- Age < 65

- Pathological fracture

- Multiple lower limb fractures

- Old fracture

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Paracetamol tablet and Tramadol capsule
Panadol 500mg tablet Q4H prn Tramadol 50mg capsule Q4H prn
Panadol 500mg tablet, tramadol 50mg capsule
Regular Panadol 500mg tds with tramadol 50mg capsule tds for 3 weeks after injury

Locations

Country Name City State
China Department of Orthopaedics and Traumatology, Queen Elizabeth Hospital Hong Kong SAR

Sponsors (1)

Lead Sponsor Collaborator
Queen Elizabeth Hospital, Hong Kong

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Functional Independency Measure(FIM) FIM including motor and cognitive function of a patient. Motor area covers self care, ambulation, bowel and bladder and etc. 2 years No
Primary Elderly Mobility Score It is to assess mobility in frail elderly people. A final score rangeing from 0-20 is assigned during several time-point of rehabilitation 2 years No